Abstract B105: Multisite single-cell immune profiling of premetastatic pancreatic ductal adenocarcinoma in a prospective clinical trial
Although pancreatic ductal adenocarcinoma (PDAC) has long been considered immunologically "cold," recent studies have revealed complexity in how neoantigen quality, T cell composition, and spatial immune organization influence patient outcomes and responsiveness to emerging immune-based therapies. However, these...